Trial intelligence / Profile preview

Immunological responses and safety after COVID-19 vaccination in healthcare workers at Siriraj Hospital, Bangkok

TCTR20210720002Phase 3Completed

Sponsor
Faculty of Medicine Siriraj Hospital, Mahidol University
Start
Mar 2021
Countries
1
01

Overview

Phase 3, open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Primary endpoints: Immunological response to COVID-19 vaccination and Safety after COVID-19 vaccination. Started Mar 2021; status: completed.

02

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on TCTR20210720002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210720002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call